Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of Bone”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03213678
What this trial is testing

Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Non-Hodgkin LymphomaAnn Arbor Stage IV Non-Hodgkin Lymphoma+30 more
National Cancer Institute (NCI) 18
Early research (Phase 1)Study completedNCT02211755
What this trial is testing

Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid Tumors

Who this might be right for
NeoplasmsMyelodysplastic SyndromesLymphomas
National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Study completedNCT01175785
What this trial is testing

Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+17 more
Nohla Therapeutics, Inc. 15
Testing effectiveness (Phase 2)WithdrawnNCT01188889
What this trial is testing

RAD001 in Patients With Chronic Phase Chronic Myeloid Leukemia w/ Molecular Disease.

Who this might be right for
Chronic Myeloid Leukemia
University of Michigan Rogel Cancer Center
Not applicableNot Yet RecruitingNCT05515068
What this trial is testing

Registry For Children, Adolescents And Adults With Osteosarcoma And Biologically Related Bone Sarcomas

Who this might be right for
OsteosarcomaBone TumorBone Sarcoma+23 more
Klinikum Stuttgart 1,000
Testing effectiveness (Phase 2)Study completedNCT01893320
What this trial is testing

Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 66
Testing effectiveness (Phase 2)Ended earlyNCT00441168
What this trial is testing

Velcade (Bortezomib), Adriamycin Dexamethasone (PAD) or Vincristine Adriamycin Dexamethasone in Second Line Treatment of Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen-Cilag International NV 30
Not applicableStudy completedNCT03223597
What this trial is testing

Registry of Treatment Outcomes of Symptomatic Metastasized Castration Resistant Prostate Cancer Treated With Radium-223

Who this might be right for
Prostate Cancer MetastaticBone Metastases
The Netherlands Cancer Institute 300
Testing effectiveness (Phase 2)Ended earlyNCT04730349
What this trial is testing

Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer

Who this might be right for
EpendymomaEwing SarcomaHigh-grade Glioma+7 more
Bristol-Myers Squibb 15
Not applicableStudy completedNCT01615640
What this trial is testing

Diffusion Study on Patients With Osteosarcoma

Who this might be right for
Osteosarcoma
Klinikum Stuttgart 30
Not applicableLooking for participantsNCT06017518
What this trial is testing

An Observational Study of Local Relapse After High Grade Osteosarcoma

Who this might be right for
Osteosarcoma
Istituto Ortopedico Rizzoli 150
Early research (Phase 1)Study completedNCT02955550
What this trial is testing

A Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion With or Without Subcutaneous Recombinant Human Interleukin-2 (rhIL-2) Following Autologous Stem Cell Transplant for Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Celularity Incorporated 15
Early research (Phase 1)Looking for participantsNCT06550713
What this trial is testing

A Clinical Trial of TQB3455 Tablets in Patients With Hematological Malignancies

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 100
Testing effectiveness (Phase 2)Study completedNCT00049179
What this trial is testing

S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia

Who this might be right for
Leukemia
SWOG Cancer Research Network 33
Not applicableEnded earlyNCT00458796
What this trial is testing

Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the Bone

Who this might be right for
Breast CancerHypercalcemia of MalignancyMetastatic Cancer+2 more
University of Leeds 1,500
Testing effectiveness (Phase 2)Ended earlyNCT02581384
What this trial is testing

Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors

Who this might be right for
Ewing SarcomaRhabdomyosarcomaWilms Tumor+8 more
Dana-Farber Cancer Institute 5
Testing effectiveness (Phase 2)Study completedNCT00071006
What this trial is testing

AG-013736 (Axitinib) In Patients With Poor Prognosis Acute Myeloid Leukemia (AML) Or Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome
Pfizer 12
Early research (Phase 1)Study completedNCT00064233
What this trial is testing

BMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Is Resistant to Imatinib Mesylate

Who this might be right for
Leukemia
Jonsson Comprehensive Cancer Center 42
Early research (Phase 1)Ended earlyNCT02429804
What this trial is testing

NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Malignant Neoplasm in the BoneMetastatic Prostate Carcinoma
Stanford University 4
Testing effectiveness (Phase 2)Temporarily pausedNCT05168904
What this trial is testing

Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome (MDS)

Who this might be right for
LeukemiaMyelodysplastic Syndrome(MDS)
Cyclacel Pharmaceuticals, Inc. 210
Next Page